ARTL MEXC RealStocks
Own real ARTL shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 16:52:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Artelo Biosciences, Inc. (ARTL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.12, with a market capitalization of $1.15M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.91 to $179.19. This page covers its latest market performance, valuation, price trends and company information.
$1.15M | |
$2.17 | |
$2.21 | |
$2.10 | |
$2.10 | |
8.35K | |
483.95K | |
-- | |
$179.19 | |
$1.91 | |
-- | |
-- |
Artelo Biosciences, Inc. (ARTL) is currently trading at $2.12 as of 2026-11-13 16:51:00, down 2.26% ($0.05) from the previous close of $2.10
During today's regular trading session, ARTL has traded between $2.10 and $2.21, with a trading volume of 8.35K shares. The current price is near the lower end of today's range.
Over the past seven days, Artelo Biosciences, Inc. (ARTL) moved from $2.12 to $2.12, representing a gain of 0.28% ($0.01).
The stock traded between $1.91 and $2.42 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 39.54 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.1%
ARTL is currently trading at $2.12, placing it 0.1% of the way from its 52-week low of $1.91 to its 52-week high of $179.19. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 7 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Artelo Biosciences, Inc. (ARTL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ARTL, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ARTL shares and USD.
ARTL Shares to USD
1.00 ARTL shares = 2.121 USD
Calculations are estimates based on the latest available price and are for reference only.